Evidence map›Paper›PMID 26673825›Full record

ReviewCurrent opinion in chemical biology2016

A roadmap for the XCMS family of software solutions in metabolomics.

Nathaniel G Mahieu, Jessica Lloyd Genenbacher, Gary J Patti

Abstract readReview
In one paragraph

Review in Current opinion in chemical biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Nontargeted Screening in Environmental Monitoring Programs: An Update.Advances in experimental medicine and biology · 2026
    Review
  7. Article
  8. Article
  9. Review
  10. Proteomic and metabolic profiling revealsbioRxiv : the preprint server for biology · 2025
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nathaniel G MahieuDepartment of Chemistry, Washington University in St. Louis, St. Louis, MO 63130, United States; Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, United States.
Jessica Lloyd GenenbacherDepartment of Chemistry, Washington University in St. Louis, St. Louis, MO 63130, United States; Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, United States.
Gary J PattiDepartment of Chemistry, Washington University in St. Louis, St. Louis, MO 63130, United States; Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, United States. Electronic address: gjpattij@wustl.edu.

Funding

DEVELOPING THE UNTARGETED METABOLOMIC WORKFLOW FOR HIGH-THROUGHPUT ANALYSESR01ES022181 · NIEHS · WASHINGTON UNIVERSITY · PI PATTI, GARY J · 2012 to 2016
$1.8M
CELL-SPECIFIC ISOTOPE LABELING TO TRACK INTERCELLULAR METABOLITE EXCHANGE IN CANCERR21CA191097 · NCI · WASHINGTON UNIVERSITY · PI PATTI, GARY J · 2015 to 2017
$663k
NCI NIH HHS R21 CA191097NIA NIH HHS L30 AG038036NIEHS NIH HHS R01 ES022181
6 · The paper itself

Abstract

Global profiling of metabolites in biological samples by liquid chromatography/mass spectrometry results in datasets too large to evaluate manually. Fortunately, a variety of software programs are now available to automate the data analysis. Selection of the appropriate processing solution is dependent upon experimental design. Most metabolomic studies a decade ago had a relatively simple experimental design in which the intensities of compounds were compared between only two sample groups. More recently, however, increasingly sophisticated applications have been pursued. Examples include comparing compound intensities between multiple sample groups and unbiasedly tracking the fate of specific isotopic labels. The latter types of applications have necessitated the development of new software programs, which have introduced additional functionalities that facilitate data analysis. The objective of this review is to provide an overview of the freely available bioinformatic solutions that are either based upon or are compatible with the algorithms in XCMS, which we broadly refer to here as the 'XCMS family' of software. These include CAMERA, credentialing, Warpgroup, metaXCMS, X(13)CMS, and XCMS Online. Together, these informatic technologies can accommodate most cutting-edge metabolomic applications and offer unique advantages when compared to the original XCMS program.

Indexed as

SoftwareArtifactsInternetMetabolomicsMolecular Sequence Annotation

Identifiers

PMID26673825
PMCPMC4831061

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.